takeda christophe weber

Julie Kim Will Succeed Christophe Weber as CEO of Takeda

Drugmaker Takeda's CEO Weber to step down, raises profit forecast

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped its full-year profit outlook. Julie Kim,

STAT · 3d

Takeda CEO Christophe Weber to step down following prolonged drop in company shares

Christophe Weber will step down as CEO of Takeda next year, the company announced, following a dropoff in its share price over the last couple of years.

YAHOO!Finance · 3d

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber,

FiercePharma2d

Fierce Pharma Asia—Takeda's next CEO; Enhertu's novel FDA nod; East Asian American C-suite execs

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed

Takeda (TAK) announced that its board of directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Julie Kim Will Succeed Christophe Weber as CEO of Takeda

Trending now